Neural basis for improgan antinociception

Neuroscience

Volumn 169, Issue 3, 2010, Pages 1414-1420

  Heinricher, M M ^a   Martenson, M E ^a   Nalwalk, J W ^b   Hough, L B ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Brainstem; OFF cells; ON cells; Pain modulation; Rostral ventromedial medulla

Indexed keywords

ANALGESIC AGENT; CANNABINOID; IMPROGAN; MU OPIATE RECEPTOR AGONIST; PLACEBO; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; EVOKED RESPONSE; IN VIVO STUDY; MALE; MECHANICAL STIMULATION; MEDULLA OBLONGATA; NEUROMODULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; THERMAL STIMULATION;

EID: 77955281760     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.05.042     Document Type: Article

References (48)

1. Aimone L.D., Gebhart G.F. Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla. J Neurosci 1986, 6:1803-1813.
2. Bannoura M.D., Nalwalk J.W., Tang Y., Carlile M., Leurs R., Menge W.M., Timmerman H., Hough L.B. Absence of antinociceptive tolerance to improgan, a cimetidine analog, in rats. Brain Res 1998, 814:218-221.
3. Barbaro N.M., Heinricher M.M., Fields H.L. Putative nociceptive modulatory neurons in the rostral ventromedial medulla of the rat display highly correlated firing patterns. Somatosens Mot Res 1989, 6:413-425.
4. Cleary D.R., Neubert M.J., Heinricher M.M. Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?. Neuroscience 2008, 151:564-571.
5. Drew G.M., Lau B.K., Vaughan C.W. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. J Neurosci 2009, 29:7220-7229.
6. Fields H.L., Bry J., Hentall I., Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci 1983, 3:2545-2552.
7. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
8. 1 receptors in improgan antinociception. J Pain 2007, 8:850-860.
9. Heinricher M.M., Barbaro N.M., Fields H.L. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness. Somatosens Mot Res 1989, 6:427-439.
10. Heinricher M.M., Ingram S.L. The brainstem and nociceptive modulation. The senses, a comprehensive reference, Vol. 5, Pain 2008, 593-626. Academic Press, San Diego, CA. M.C. Bushnell, A.I. Basbaum (Eds.).
11. Heinricher M.M., McGaraughty S., Farr D.A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 1999, 81:57-65.
12. Heinricher M.M., McGaraughty S., Tortorici V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 2001, 85:280-286.
13. Heinricher M.M., Morgan M.M., Fields H.L. Direct and indirect actions of morphine on medullary neurons that modulate nociception. Neuroscience 1992, 48:533-543.
14. Heinricher M.M., Morgan M.M., Tortorici V., Fields H.L. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 1994, 63:279-288.
15. Heinricher M.M., Roychowdhury S. Reflex-related activation of putative pain facilitating neurons in rostral ventromedial medulla (RVM) depends upon excitatory amino acid transmission. Neuroscience 1997, 78:1159-1165.
16. Heinricher M.M., Schouten J.C., Jobst E.E. Activation of brainstem n-methyl-7d-aspartate receptors is required for the analgesic actions of morphine given systemically. Pain 2001, 92:129-138.
17. Heinricher M.M., Tavares I., Leith J.L., Lumb B.M. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 2009, 60:214-225.
18. Heinricher M.M., Tortorici V. Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 1994, 63:533-546.
19. Hough L.B. Improgan-like analgesics: a family of compounds derived from histamine antagonists. Med Chem Res 2004, 13:78-87.
20. Hough L.B., de Esch I.J., Janssen E., Phillips J., Svokos K., Kern B., Trachler J., Abood M.E., Leurs R., Nalwalk J.W. Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic. Neuropharmacology 2006, 51:447-456.
21. Hough L.B., Menge W.M., van de Stolpe A.C., Nalwalk J.W., Leurs R., De Esch I.J. Antinociceptive activity of furan-containing congeners of improgan and ranitidine. Bioorg Med Chem Lett 2007, 17:5715-5719.
22. Hough L.B., Nalwalk J.W., Chen Y., Schuller A., Zhu Y., Zhang J., Menge W.M., Leurs R., Timmerman H., Pintar J.E. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice. Brain Res 2000, 880:102-108.
23. Hough L.B., Nalwalk J.W., Leurs R., Menge W.M., Timmerman H. Antinociceptive activity of derivatives of improgran and burimamide. Pharmacol Biochem Behav 2000, 65:61-66.
24. Hough L.B., Nalwalk J.W., Leurs R., Menge W.M., Timmerman H. Significance of GABAergic systems in the action of improgan, a non-opioid analgesic. Life Sci 2001, 68:2751-2757.
25. Hough L.B., Nalwalk J.W., Lu Q., Shan Z., Svokos K., Wentland M.P., Montero M.J. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic. Eur J Pharmacol 2005, 522:38-46.
26. 1 receptors. J Pharmacol Exp Ther 2002, 303:314-322.
27. Hough L.B., Svokos K., Nalwalk J.W. Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms. Brain Res 2009, 1247:62-70.
28. Jensen T.S., Yaksh T.L. Comparison of the antinociceptive effect of morphine and glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats. Brain Res 1989, 476:1-9.
29. Lau B.K., Vaughan C.W. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Mol Pharmacol 2008, 74:1392-1398.
30. Li B.Y., Nalwalk J.W., Barker L.A., Cumming P., Parsons M.E., Hough L.B. Characterization of the antinociceptive properties of cimetidine and a structural analog. J Pharmacol Exp Ther 1996, 276:500-508.
31. Li B.Y., Nalwalk J.W., Finkel J.M., Glick S.D., Hough L.B. SKF92374, a cimetidine analog, produces mechanical and thermal antinociception in the absence of motor impairment. Analgesia 1997, 3:15-20.
32. Lovick T.A. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats. Pain 1985, 21:241-252.
33. Lovick T.A. Analgesia and the cardiovascular changes evoked by stimulating neurones in the ventrolateral medulla in rats. Pain 1986, 25:259-268.
34. Lovinger D.M. Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 2008, 184:435-477.
35. Meng I.D., Johansen J.P. Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist. Neuroscience 2004, 124:685-693.
36. Meng I.D., Manning B.H., Martin W.J., Fields H.L. An analgesia circuit activated by cannabinoids. Nature 1998, 395:381-383.
37. Mobarakeh J.I., Nalwalk J.W., Watanabe T., Sakurada S., Hoffman M., Leurs R., Timmerman H., Silos-Santiago I., Yanai K., Hough L.B. Improgan antinociception does not require neuronal histamine or histamine receptors. Brain Res 2003, 974:146-152.
38. 1 receptor. Eur J Pharmacol 2006, 549:79-83.
39. Nalwalk J.W., Svokos K., Leurs R., Hough L.B. Absence of 5-HT3 and cholinergic mechanisms in improgan antinociception. Pharmacol Biochem Behav 2005, 80:505-510.
40. Nalwalk J.W., Svokos K., Taraschenko O., Leurs R., Timmerman H., Hough L.B. Activation of brain stem nuclei by improgan, a non-opioid analgesic. Brain Res 2004, 1021:248-255.
41. Neubert M.J., Kincaid W., Heinricher M.M. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain 2004, 110:158-165.
42. Pan Z.Z., Williams J.T., Osborne P.B. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Physiol 1990, 427:519-532.
43. Proudfit H.K. Reversible inactivation of raphe magnus neurons: effects on nociceptive threshold and morphine-induced analgesia. Brain Res 1980, 201:459-464.
44. Salussolia C.L., Nalwalk J.W., Hough L.B. Improgan-induced hypothermia: a role for cannabinoid receptors in improgan-induced changes in nociceptive threshold and body temperature. Brain Res 2007, 1152:42-48.
45. Sandkühler J., Gebhart G.F. Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital-anesthetized rat. Brain Res 1984, 305:77-87.
46. Vaughan C.W., McGregor I.S., Christie M.J. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br J Pharmacol 1999, 127:935-940.
47. Young E.G., Watkins L.R., Mayer D.J. Comparison of the effects of ventral medullary lesions on systemic and microinjection morphine analgesia. Brain Res 1984, 290:119-129.
48. Zorman G., Hentall I.D., Adams J.E., Fields H.L. Naloxone-reversible analgesia produced by microstimulation in the rat medulla. Brain Res 1981, 219:137-148.